SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-005728
Filing Date
2017-08-02
Accepted
2017-08-02 16:34:59
Documents
62
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20170630x10q.htm 10-Q 1548453
2 EX-10.1 bpmc-20170630ex101b7ab61.htm EX-10.1 99542
3 EX-10.2 bpmc-20170630ex102cae605.htm EX-10.2 118295
4 EX-31.1 bpmc-20170630ex311156b9e.htm EX-31.1 17832
5 EX-31.2 bpmc-20170630ex312a9a5a7.htm EX-31.2 17887
6 EX-32.1 bpmc-20170630ex3215fb292.htm EX-32.1 13896
7 GRAPHIC bpmc20170630ex101b7ab61001.jpg GRAPHIC 655
  Complete submission text file 0001558370-17-005728.txt   5672794

Data Files

Seq Description Document Type Size
8 EX-101.INS bpmc-20170630.xml EX-101.INS 997009
9 EX-101.SCH bpmc-20170630.xsd EX-101.SCH 44000
10 EX-101.CAL bpmc-20170630_cal.xml EX-101.CAL 39239
11 EX-101.DEF bpmc-20170630_def.xml EX-101.DEF 180118
12 EX-101.LAB bpmc-20170630_lab.xml EX-101.LAB 443642
13 EX-101.PRE bpmc-20170630_pre.xml EX-101.PRE 320919
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 171000408
SIC: 2834 Pharmaceutical Preparations